K. Schultz

发表

Pediatric chronic myeloid leukemia is a unique disease that requires a different approach.

N. Hijiya, K. Schultz, M. Metzler, 2016, Blood.

Chronic graft-versus-host disease (GVHD) in children.

K. Baird, K. Schultz, K. Cooke, 2010, Pediatric clinics of North America.

Chronic Graft-Versus-Host Disease in Children

K. Schultz, D. Jacobsohn, G. Vogelsang, 2006 .

Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS gene

L. Notarangelo, T. Morio, H. Ochs, 2014, Journal of Clinical Immunology.

Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium.

Allen R. Chen, M. Cairo, E. Horwitz, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Philadelphia chromosome-positive acute lymphoblastic leukemia in children: new and emerging treatment options

B. Camitta, K. Schultz, T. Prestidge, 2010, Expert review of hematology.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

M. Turner, J. Wingard, Stephanie J. Lee, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.

James Ferrara, Peter A Lachenbruch, Daniel Couriel, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.

L. Gerber, J. Bolaños-Meade, Stephanie J. Lee, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.

N. Heerema, H. Sather, S. Hunger, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pigmented Hypertrichotic Dermatosis and Insulin Dependent Diabetes: Manifestations of a Unique Genetic Disorder?

M. Rogers, A. Junker, M. Wong, 2007, Pediatric dermatology.

Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research

M. Horowitz, J. Pidala, Stephanie J. Lee, 2016, Haematologica.

The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML)

J. Harbott, F. Locatelli, S. Fenu, 2004, Leukemia.

The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia.

P. Greenberg, K. Schultz, K. HayGlass, 1990, Science.

ETV6 (TEL)‐AML1 pre‐B acute lymphoblastic leukaemia cells are associated with a distinct antigen‐presenting phenotype

P. Sorensen, G. Reid, K. Schultz, 2002, British journal of haematology.

Obstructive lung disease in children after allogeneic bone marrow transplantation: evaluation with high-resolution CT.

D. Wensley, R. Cairns, K. Schultz, 1995, AJR. American journal of roentgenology.

Multiple breath washout testing to identify pulmonary chronic graft versus host disease in children after haematopoietic stem cell transplantation.

K. Schultz, J. Rayment, R. Sandoval, 2022, Transplantation and cellular therapy.

Obstructive lung disease in children after allogeneic bone marrow transplantation.

J. F. Magee, D. Wensley, K. Schultz, 1994, Blood.

Hematopoietic cell transplantation and cellular therapeutics in the treatment of childhood malignancies.

L. Lum, K. Schultz, K. Mallhi, 2015, Pediatric clinics of North America.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report.

J. Ritz, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.

M. Aljurf, J. Szer, R. Gale, 2019, Blood advances.

Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants.

M. Norkin, H. Nakasone, M. Aljurf, 2018, Blood advances.

Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.

M. Aljurf, M. Horowitz, R. Gale, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials.

Stephanie J. Lee, Paul J. Martin, L. M. Griffith, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A population‐based study of pediatric anaplastic large cell lymphoma

K. Schultz, S. Pritchard, A. Alessandri, 2002, Cancer.

TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521).

S. Grupp, B. Langholz, E. White, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.

A. Zander, M. Horowitz, J. Liesveld, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Towards a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.

B. Banas, G. Cuvelier, W. Kimberly, 2022, Transplantation and cellular therapy.

Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial.

T. Panzarella, G. Devins, Stephanie J. Lee, 2016, The Lancet. Oncology.

NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

K. Washington, T. Morton, D. Kleiner, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

M. Washington, Z. Argényi, A. Rashid, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Circulating Angiogenic Factors Associated with Response and Survival in Patients with Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802 Biol Blood Marrow Transplant .

Gabrielle, Meyers, G. Vercellotti, 2015 .

Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study

M. Sulis, M. Hermiston, A. Place, 2018, Leukemia.

New frontiers in pediatric Allo-SCT: novel approaches for children and adolescents with ALL

M. Pulsipher, K. Schultz, A. Wayne, 2014, Bone Marrow Transplantation.

Transplantation for Childhood Acute Lymphoblastic Leukemia

G. Reid, D. Wall, K. Schultz, 2006 .

Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease.

G. Reid, Zhengjia Chen, Kevin She, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?

Amanda M Li, G. Cuvelier, J. Rozmus, 2022, Frontiers in Pediatrics.

Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.

G. Cuvelier, Zhengjia Chen, A. Kariminia, 2008, Blood.

Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma.

G. Blair, C. Fryer, K. Goddard, 2000, Medical and pediatric oncology.

Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation

M. Norkin, S. Choi, M. Qayed, 2021, Blood advances.

Controversies of and unique issues in hematopoietic cell transplantation for infant leukemia.

S. Hunger, K. Schultz, K. Baker, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?

I. Yaniv, K. Schultz, M. Suttorp, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Altered patterns of T cell cytokine production induced by relapsed pre-B ALL cells.

G. Reid, P. Gaynon, K. Schultz, 2003, Leukemia research.

Tumor Variant Identification That Accounts for the Unique Molecular Landscape of Pediatric Malignancies

J. Biegel, T. Triche, G. Reid, 2018, JNCI cancer spectrum.

Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.

B. Storer, T. Panzarella, M. Aljurf, 2016, Blood.

Monitoring Neurocognitive Functioning After Pediatric Cellular Therapy or Hematopoietic Cell Transplant: Guidelines From the COG Neurocognition in Cellular Therapies Task Force

J. Chewning, S. Braniecki, W. Pelletier, 2022, Transplantation and cellular therapy.

HISTOPATHOLOGIC DIAGNOSIS OF CHRONIC GRAFT VERSUS HOST DISEASE 2014 NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: II. Pathology Working Group Report

M. Washington, Z. Argényi, A. Rashid, 2006 .

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.

J. Pidala, S. Santarone, Stephanie J. Lee, 2013, Blood.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report.

G. Cuvelier, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

Cardiac manifestations of graft-versus-host disease.

K. Schultz, F. Goldman, K. Chan, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Is any donor too old?

K. Schultz, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Excess of veno-occlusive disease in a randomized clinical trial on a higher trigger for red blood cell transfusion after bone marrow transplantation: a canadian blood and marrow transplant group trial.

J. Lacroix, H. Bittencourt, K. Schultz, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report.

J. Pidala, H. Greinix, V. Bhatt, 2021, Transplantation and cellular therapy.

Biomarkers for Chronic Graft-versus-Host isease : National Institutes of Health Consensus evelopment Project on Criteria for Clinical Trials n Chronic Graft-versus-Host Disease : III . Biomarker orking Group Report

P. Lachenbruch, D. Miklos, E. Holler, 2006 .

Chloroquine treatment affects T-cell priming to minor histocompatibility antigens and graft-versus-host disease.

Wei Li, J. Paquet, K. Schultz, 1995, Blood.

Urine Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 to Detect Pediatric Cisplatin-Associated Acute Kidney Injury

C. Ross, B. Carleton, G. Cuvelier, 2021, Kidney360.

Epidemiologic Characteristics of Acute Kidney Injury During Cisplatin Infusions in Children Treated for Cancer

C. Ross, B. Carleton, G. Cuvelier, 2020, JAMA network open.

Biomarkers in chronic graft-versus-host disease

J. Rozmus, K. Schultz, 2011, Expert review of hematology.

Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.

S. Pai, C. Bollard, M. Pulsipher, 2018, Blood.

ncillary Therapy and Supportive Care of Chronic raft-versus-Host Disease : National Institutes of ealth Consensus Development Project on Criteria or Clinical Trials in Chronic Graft-versus-Host isease : V . Ancillary Therapy and Supportive Care orking Group Report

L. Gerber, J. Bolaños-Meade, Stephanie J. Lee, 2006 .

Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromes.

M. Dan, L. Lum, K. Schultz, 1993, Blood.

Monoclonal antibody therapy of murine lymphoma: enhanced efficacy by concurrent administration of interleukin 2 or lymphokine-activated killer cells.

I. Bernstein, P. Greenberg, D. Peace, 1990, Cancer research.

Verbal Permission to Obtain Clinically Urgent Bio-Specimens for a Paediatric Biobank

C. Strahlendorf, S. Vercauteren, K. Schultz, 2014 .

Y-box-binding protein 1 contributes to IL-7-mediated survival signaling in B-cell precursor acute lymphoblastic leukemia.

G. Reid, S. Dunn, A. Kariminia, 2017, Oncology letters.

In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides.

D. Teachey, J. Fish, G. Reid, 2006, Blood.

EBMT—NIH—CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

E. Holler, H. Greinix, Stephanie J. Lee, 2018, Bone Marrow Transplantation.

Canadian multicenter pilot trial of haploidentical donor transplantation.

C. Sigouin, R. Foley, N. Shehata, 2004, Blood cells, molecules & diseases.

Biomarkers in chronic graft-versus-host disease: quo vadis?

E. Weissinger, E. Holler, J. Hansen, 2018, Bone Marrow Transplantation.

HISTOPATHOLOGIC DIAGNOSIS OF CHRONIC GRAFT VERSUS HOST DISEASE: NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: II. The 2014 Pathology Working Group Report

T. Morton, D. Kleiner, J. Greenson, 2015 .

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report.

S. Hirschfeld, Stephanie J. Lee, M. Flowers, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Practice Patterns of Physician Treatment for Pediatric Chronic Myelogenous Leukemia.

N. Hijiya, K. Schultz, M. Burke, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group

D. Johnston, H. Bittencourt, N. Hijiya, 2019, Pediatric blood & cancer.

How we approach Philadelphia chromosome‐positive acute lymphoblastic leukemia in children and young adults

L. Silverman, S. Hunger, W. Slayton, 2020, Pediatric blood & cancer.

Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study

B. Burkhardt, M. Schrappe, H. Ariffin, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation

E. Estey, B. Sandmaier, M. Krem, 2021, Bone Marrow Transplantation.

Acute kidney injury during cisplatin therapy and associations with kidney outcomes 2 to 6 months post-cisplatin in children: a multi-centre, prospective observational study

C. Ross, B. Carleton, G. Cuvelier, 2022, Pediatric Nephrology.

Differential killing of pre‐B acute lymphoblastic leukaemia cells by activated NK cells and the NK‐92 ci cell line

G. Reid, K. Schultz, H. Klingemann, 2002, Clinical and experimental immunology.

S. Spellman, J. Panepinto, B. Logan, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia

K. Schultz, D. Subburaj, 2022, Clinical Management of Acute Lymphoblastic Leukemia.

Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T‐acute lymphoblastic leukemia and T‐lymphoblastic lymphoma (study T2008‐002 NECTAR)

L. Silverman, B. Wood, A. Attarbaschi, 2022, Pediatric blood & cancer.

IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.

P. Greenberg, D. Peace, M. Cheever, 1988, Journal of immunology.

CD56brightCD16- natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease

G. Cuvelier, A. Kariminia, M. Levings, 2022, Haematologica.

Ibrutinib treatment of pediatric chronic graft-versus-host disease: primary results from the phase 1/2 iMAGINE study.

G. Lucchini, K. Yoo, E. Nemecek, 2022, Transplantation and cellular therapy.

The Future of Chronic Graft-Versus-Host Disease: Introduction to the 2020 National Institutes of Health Consensus Development Project Reports.

Stephanie J. Lee, Paul J. Martin, S. Pavletic, 2021, Transplantation and cellular therapy.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report Transplantation and Cellular Therapy

J. Pidala, H. Greinix, V. Bhatt, 2021 .

Benefits and challenges with diagnosing chronic and late acute GvHD in children using the NIH consensus criteria.

J. Chewning, G. Cuvelier, D. Coulter, 2019, Blood.

Hydroxychloroquine for the treatment of chronic graft-versus-host disease.

M. Boyer, K. Schultz, F. Goldman, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher levels of free plasma mitochondrial DNA are associated with the onset of chronic GvHD

J. Lipton, A. Kariminia, Stephanie J. Lee, 2018, Bone Marrow Transplantation.

Chronic gvhd dictionary—eurograft cost action initiative consensus report

H. Greinix, Stephanie J. Lee, D. Pulanić, 2022, Bone Marrow Transplantation.

Paroxysmal nocturnal haemoglobinuria phenotype cells and leucocyte subset telomere length in childhood acquired aplastic anaemia

K. Schultz, G. Aubert, R. Deyell, 2014, British journal of haematology.

Prediction of area under the cyclosporine concentration versus time curve in children undergoing hematopoietic stem cell transplantation.

R. Egeler, L. Dupuis, K. Schultz, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Synergy between lysosomotropic amines and cyclosporin A on human T cell responses to an exogenous protein antigen, tetanus toxoid.

D. Nelson, K. Schultz, D. Nelson, 1996, Bone marrow transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report Transplantation and Cellular Therapy

Shannon R. McCurdy, R. Jenq, R. Lafyatis, 2021 .

Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length

Amanda M Li, R. Schreiber, S. Stockler-Ipsiroglu, 2018, Pediatric hematology and oncology.

oligonucleotides In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG

D. Teachey, J. Fish, G. Reid, 2013 .

Characteristics of Graft-versus-Host Disease (GvHD) after Post-transplant Cyclophosphamide versus Conventional GvHD Prophylaxis.

M. Perales, J. Pidala, C. Abboud, 2022, Transplantation and cellular therapy.

Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure.

H. Deeg, J. Wagner, R. Gale, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplant Consortium study graft-versus-host disease in children: a Pediatric Blood and Marrow Evaluation of pentostatin in corticosteroid-refractory chronic

A. Rademaker, E. Nemecek, K. Schultz, 2013 .

Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study.

A. Rademaker, E. Nemecek, L. Lehmann, 2009, Blood.

Successful clinical treatment and functional immunological normalization of human MALT1 deficiency following hematopoietic stem cell transplantation.

J. Rozmus, M. McKinnon, S. Turvey, 2016, Clinical immunology.

Absence of t(12;15) associated ETV6-NTRK3 fusion transcripts in pediatric acute leukemias.

P. Sorensen, S. Knezevich, J. Mathers, 2001, Medical and pediatric oncology.

Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens.

A. Kariminia, S. Ivison, K. Schultz, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The lysosomotropic amines, chloroquine and hydroxychloroquine: a potentially novel therapy for graft-versus-host disease.

K. Schultz, A. Gilman, 1997, Leukemia & lymphoma.

Biology-Driven Classification of Childhood Acute Lymphoblastic Leukemia: A Combined Analysis of Prognostic Markers from the Pediatric Oncology Group (POG) and Children’s Cancer Group (CCG).

J. Shuster, N. Heerema, H. Sather, 2004 .

Successful rescue transplant for children with primary graft failure using early intervention with a single day preparative regimen and related haploidentical donor

Amanda M Li, J. Rozmus, K. Schultz, 2021, Bone Marrow Transplantation.

B ational Institutes of Health Consensus Development roject on Criteria for Clinical Trials in Chronic raft-versus-Host Disease : I . Diagnosis and Staging orking Group Report

M. Turner, J. Wingard, Stephanie J. Lee, 2005 .

Increased TLR9 Responses in B Cells at the Onset of Chronic GVHD: 36

Kevin She, K. Schultz, A. Gilman, 2005 .

Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD

M. Norkin, S. Furlan, M. Pasquini, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression.

Allen R. Chen, S. Meshinchi, M. Loken, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Amanda M Li, S. Mostafavi, R. Brinkman, 2020, Frontiers in Immunology.

ATG prophylaxis Induces A Decrease in Naïve Th cells to Inhibit the Onset of Chronic GvHD (cGvHD): Results from the Canadian BMT Group (CBMTG) 0801 study.

A. Kariminia, M. Irvine, K. Schultz, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.

B. Storer, A. Kariminia, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD.

C. Eaves, A. Kariminia, S. Ivison, 2018, Blood.

New Answers to Old Conundrums: What Antibodies, Exosomes and Inflammasomes Bring to the Conversation. Canadian National Transplant Research Program International Summit Report

T. Mohanakumar, R. Fairchild, C. Cairo, 2017, Transplantation.

Outcome of hematopoietic cell transplantation for DNA double‐strand break repair disorders

A. Fischer, A. Schulz, A. Gennery, 2018, The Journal of allergy and clinical immunology.

Monoclonal Antibody Therapy of Murine Lymphoma: Enhanced Efficacy by Concurrent Administration of Interleukin 2 or Lymphokine-activated Killer Cells1

I. Bernstein, P. Greenberg, Christopher, 2006 .

Lymphokine-activated Killer Cells Efficacy by Concurrent Administration of Interleukin 2 or Monoclonal Antibody Therapy of Murine Lymphoma : Enhanced Updated

I. Bernstein, P. Greenberg, D. Peace, 2006 .

Monoclonal Antibody Therapy of Murine Lymphoma : Enhanced Efficacy by Concurrent Administration of Interleukin 2 or Lymphokine-activated Killer Cells 1

I. Bernstein, P. Greenberg, Christopher, 2006 .

Imatinib resistant BCR‐ABL1 mutations at relapse in children with Ph+ALL: a Children's Oncology Group (COG) study

B. Druker, S. Hunger, N. Winick, 2012, British journal of haematology.

Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease.

K. Schultz, J. Paquet, S. Bader, 1995, Bone marrow transplantation.

Detection of WT1‐specific T cells in paediatric acute lymphoblastic leukaemia patients in first remission

G. Reid, W. Jastaniah, K. Schultz, 2008, British journal of haematology.

Use of G‐CSF in Matched Sibling Donor Pediatric Allogeneic Transplantation: A Consensus Statement from the Children's Oncology Group (COG) Transplant Discipline Committee and Pediatric Blood and Marrow Transplant Consortium (PBMTC) Executive Committee

S. Grupp, M. Pulsipher, H. Frangoul, 2006, Pediatric blood & cancer.

Inferior outcomes with reduced intensity conditioning followed by allogeneic hematopoietic cell transplantation in fit individuals with acute lymphoblastic leukemia: a Canadian single-center study and a comparison to registry data

J. Lipton, K. Schultz, Rajat Kumar, 2021, Leukemia & lymphoma.

Severe Combined Immunodeficiency (SCID) in Canadian Children: A National Surveillance Study

J. Langley, Elie Haddad, J. Rozmus, 2013, Journal of Clinical Immunology.

Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.

G. Vercellotti, M. MacMillan, D. Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors of lost to follow-up among pediatric and adult hematopoietic cell transplant survivors: A report from the Center for International Blood and Marrow Transplant Research.

W. Wood, M. Aljurf, A. Yoshimi, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

J. Wingard, J. Gea-Banacloche, S. Paczesny, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.

Shannon R. McCurdy, R. Jenq, G. Cuvelier, 2021, Transplantation and cellular therapy.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report

G. Cuvelier, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.

W. Wood, A. Nagler, M. Mohty, 2022, Transplantation and cellular therapy.

A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.

Mei-Jie Zhang, David D. Smith, David D Smith, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.

J. Klein, M. Tallman, A. Keating, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunosuppressive therapy: a potential alternative to bone marrow transplantation as initial therapy for acquired severe aplastic anemia in childhood?

C. Fryer, K. Schultz, E. Lawlor, 1997, Journal of pediatric hematology/oncology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Anita Lawitschka, Stephanie J. Lee, K. Syrjala, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immune Profile Differences between Chronic GvHD and Late Acute GvHD: Results of the ABLE/PBMTC 1202 Studies.

S. Mostafavi, J. Chewning, G. Cuvelier, 2020, Blood.

The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: Report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York

V. Caviness, M. Patterson, C. Whitley, 2009, Genetics in Medicine.

Measuring Therapeutic Response in Chronic Graft-versus-host-disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus- Host Disease: Iv. Response Criteria Working Group Report

Daniel Wolff, Anita Lawitschka, Sandra A. Mitchell, 2022 .

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

John P Klein, Daniel J Weisdorf, Peter Greenberg, 2004, Blood.

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

Steven Hirschfeld, Lynn H. Gerber, Sandra A. Mitchell, 2006 .

Impact of conditioning regimen in allogeneic hematopoetic stem cell transplantation for children with acute myelogenous leukemia beyond first complete remission: a pediatric blood and marrow transplant consortium (PBMTC) study.

T. Koyama, M. Pulsipher, H. Frangoul, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.

J. Klein, W. Wood, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622.

M. Loh, J. Gastier-Foster, N. Heerema, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss.

A. Gedman, A. Weng, M. J. You, 2009, Blood.

Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemia.

P. Gaynon, L. Wadsworth, K. Schultz, 1997, Medical and pediatric oncology.

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

M. Loh, J. Shuster, N. Heerema, 2007, Blood.

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research

R. Vij, B. Sandmaier, M. Aljurf, 2019, Haematologica.

Combined immunodeficiency associated with homozygous MALT1 mutations.

R. Holt, M. Seear, J. Rozmus, 2014, The Journal of allergy and clinical immunology.

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.

Medhat Askar, Effie W Petersdorf, Kwang Woo Ahn, 2014, Blood.

Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.

M. Loh, J. Gastier-Foster, Zhiguo Chen, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group.

M. Loh, J. Gastier-Foster, N. Heerema, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

J. Ritz, D. Miklos, M. V. D. van den Brink, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chloroquine prevention of murine MHC-disparate acute graft-versus-host disease correlates with inhibition of splenic response to CpG oligodeoxynucleotides and alterations in T-cell cytokine production.

G. Doho, K. Schultz, C. Hsiao, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report.

N. Heerema, H. Sather, M. Trigg, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients.

C. Desmarais, C. Carlson, J. Gastier-Foster, 2015, Blood.

Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes.

J. Klein, J. Sierra, M. Horowitz, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy.

P. Sorensen, K. Schultz, Jeff Davis, 2003, Medical and pediatric oncology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.

D. Miklos, J. Pidala, E. Russek-Cohen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Tao Wang, Thomas Spitzer, Daniel J Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis.

W. Wood, K. Sullivan, M. Aljurf, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study.

S. Grupp, B. Langholz, Zhengjia Chen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immune suppression by lysosomotropic amines and cyclosporine on T-cell responses to minor and major histocompatibility antigens: does synergy exist?

M. Wang, K. Schultz, K. HayGlass, 1997, Transplantation.

A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: A Children's Oncology Group study

P. Adamson, A. Pappo, M. Bernstein, 2008, Pediatric blood & cancer.

More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling.

Allen R. Chen, M. Bar, V. V. D. van der Velden, 2019, Blood advances.

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007.

F. Appelbaum, H. Heslop, M. Horowitz, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.

Effie W Petersdorf, John Horan, Michelle Setterholm, 2010, Blood.

Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)

M. Sulis, L. Silverman, J. Whitlock, 2022, Haematologica.

Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia.

A. Gratwohl, R. Gale, P. Tiberghien, 2000, Blood.

Experience with ponatinib in paediatric patients with leukaemia

M. Sulis, C. Zwaan, N. Hijiya, 2020, British journal of haematology.

Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens.

S. Davies, P. Mehta, M. Cairo, 2014, Blood.

Severe Combined Immunodeficiency (SCID) in Canadian Children: A National Surveillance Study

R. Long, E. Haddad, J. Langley, 2013, Journal of Clinical Immunology.

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

P. Lachenbruch, B. Reeve, S. Hirschfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Optimizing outcomes of hematopoietic stem cell transplantation for severe combined immunodeficiency.

G. Cuvelier, S. Turvey, A. Junker, 2009, Clinical immunology.

Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs.

L. Notarangelo, J. Puck, K. Sullivan, 2008, The Journal of allergy and clinical immunology.

Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031.

S. Grupp, A. Kariminia, J. Rozmus, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.

R. Vij, M. Aljurf, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft failure in children receiving HLA-mismatched marrow transplants with busulfan-containing regimens.

Y. Ravindranath, E. Abella, L. Lum, 1994, Bone marrow transplantation.

Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes.

J. Wagner, J. Kurtzberg, M. Horowitz, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Multicenter Investigation Of Unrelated Donor Hematopoietic Cell Transplantation (HCT) For Thalassemia Major After a Reduced Intensity Conditioning Regimen (URTH Trial)

E. Neufeld, F. Trachtenberg, A. Thompson, 2013 .

CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results

S. Mostafavi, T. Panzarella, M. Aljurf, 2017, Haematologica.

Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation.

M. Aljurf, Stephanie J. Lee, S. Marsh, 2014, Blood.

What Is the Role of HSCT in Philadelphia-Chromosome–Positive and Philadelphia-Chromosome–Like ALL in the Tyrosine Kinase Inhibitor Era?

J. Buechner, K. Vettenranta, K. Schultz, 2022, Frontiers in Pediatrics.

The impact of Asian descent on the incidence of acquired severe aplastic anaemia in children

M. McBride, K. Schultz, P. Rogers, 2003, British journal of haematology.

Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT.

M. Aljurf, R. Gale, J. Pidala, 2020, Journal of Clinical Oncology.

In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children.

J. Wagner, M. Perales, R. Sparapani, 2015, Biology of Blood and Marrow Transplantation.

One-unit versus two-unit cord-blood transplantation for hematologic cancers.

J. Wagner, J. Kurtzberg, M. Horowitz, 2014, The New England journal of medicine.

Umbilical Cord Blood Transplantation in Children with Acute Leukemia : Impact of Conditioning on Transplant Outcomes Short Title : Cord Blood Transplant for Acute Leukemia

J. Wagner, J. Kurtzberg, M. Horowitz, 2017 .

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.

B. Sandmaier, M. Aljurf, R. Gale, 2019, Blood advances.

Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial

T. Panzarella, G. Devins, Stephanie J. Lee, 2014 .

Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.

T. Panzarella, G. Devins, Stephanie J. Lee, 2020, The Lancet. Haematology.

Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7.

J. Harbott, S. Fenu, I. Baumann, 2003, Blood.

Functional hyposplenism after hematopoietic stem cell transplantation

J. Rozmus, K. Schultz, K. Mallhi, 2015, Bone Marrow Transplantation.

Immunosuppressive Therapy Without Hematopoietic Growth Factor Exposure in Pediatric Acquired Aplastic Anemia

K. Schultz, R. Deyell, E. Shereck, 2011, Pediatric hematology and oncology.

Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers

L. Notarangelo, J. Puck, T. Torgerson, 2020, Journal of Clinical Immunology.

Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers

L. Notarangelo, J. Puck, T. Torgerson, 2020, Journal of Clinical Immunology.

HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival.

H. Deeg, B. George, J. Passweg, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Differential effects of granulocyte colony-stimulating factor on marrow- and blood-derived hematopoietic and immune cell populations in healthy human donors.

C. Eaves, T. Panzarella, S. Imren, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CpG stimulation of precursor B-lineage acute lymphoblastic leukemia induces a distinct change in costimulatory molecule expression and shifts allogeneic T cells toward a Th1 response.

G. Reid, Kevin She, K. Schultz, 2005, Blood.

Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.

A. Gennery, M. Aljurf, B. George, 2019, Blood advances.

Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study.

D. Fairclough, T. Panzarella, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Quantitation of Human Cells that Produce Neutrophils and Platelets in Vivo Obtained from Normal Donors Treated with Granulocyte Colony-Stimulating Factor and/or Plerixafor.

C. Eaves, D. Knapp, P. Miller, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Heterodimer‐specific TLR2 stimulation results in divergent functional outcomes in B‐cell precursor acute lymphoblastic leukemia

G. Reid, A. Kariminia, S. Ivison, 2015, European journal of immunology.

The case for plerixafor to replace filgrastim as the optimal agent to mobilize peripheral blood donors for allogeneic hematopoietic cell transplantation.

K. Schultz, S. Couban, Peggy P. C. Wong, 2019, Experimental hematology.

Impact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study

B. Kurland, J. Pidala, M. Arora, 2013, Leukemia.

Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Regional differences in access to hematopoietic stem cell transplantation among pediatric patients with acute myeloid leukemia

G. Cuvelier, H. Bittencourt, J. Pole, 2020, Pediatric blood & cancer.

Investigating the biology of relapsed acute leukemia: Proceedings of the Therapeutic Advances for Childhood Leukemia & Lymphoma (TACL) Consortium Biology Working Group

M. Sulis, S. Izraeli, B. Chang, 2017, Pediatric hematology and oncology.

Elevated ADA2 enzyme activity at the onset of chronic graft-versus-host disease in children.

K. Brown, G. Cuvelier, A. Kariminia, 2023, Transplantation and cellular therapy.

A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study

J. Chewning, G. Cuvelier, B. Ng, 2022, Blood advances.

Metabolomic Identification of Alpha-Ketoglutaric Acid Elevation in Pediatric Chronic Graft-versus-Host Disease.

J. Chewning, G. Cuvelier, A. Kariminia, 2021, Blood.

Anti-CD13 antibodies in children with extensive chronic graft-versus-host disease and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031

S. Grupp, S. Dunn, G. Cuvelier, 2010, Bone Marrow Transplantation.

Molecular and phenotypic diversity of CBLmutated juvenile myelomonocytic leukemia

M. Loh, A. Olshen, M. Sulis, 2020, Haematologica.

Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?

J. Gastier-Foster, D. Teachey, S. Grupp, 2015, Bone Marrow Transplantation.

The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial.

J. Gastier-Foster, D. Teachey, S. Grupp, 2014, Blood.

Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide–total body irradiation versus busulphan–cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission

J. Klein, R. Gale, M. Trigg, 2002, British journal of haematology.

The pharmacokinetics of oral cyclosporin A (Neoral) during the first month after bone marrow transplantation.

P. Keown, K. Schultz, C. Toze, 1998, Transplantation proceedings.

Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study

C. Ross, B. Carleton, S. Baruchel, 2017, Canadian journal of kidney health and disease.

A Germline Mutation in the C2 Domain of PLCγ2 Associated with Gain-of-Function Expands the Phenotype for PLCG2-Related Diseases

M. Hannibal, A. Kariminia, D. O’Dwyer, 2019, Journal of Clinical Immunology.

Chronic Graft versus Host Disease: Interdisciplinary Management: Pathophysiology of Chronic Graft versus Host Disease

K. Schultz, 2009 .

Inflammatory Markers and Autoantibodies That Correlate with Early and Late Onset of New Onset Pediatric Chronic Graft-Versus-Host Disease (GVHD).

Zhengjia Chen, Kevin She, M. Krailo, 2006 .

Will post-transplantation cell therapies for pediatric patients become standard of care?

S. Grupp, C. Bollard, F. Locatelli, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved Early Event Free Survival (EFS) in Children with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) with Intensive Imatinib in Combination with High Dose Chemotherapy: Children’s Oncology Group (COG) Study AALL0031.

N. Heerema, H. Sather, S. Hunger, 2007 .

A population‐based study of childhood myelodysplastic syndrome in British Columbia, Canada

M. McBride, L. Wadsworth, H. Hasle, 1999, British journal of haematology.

Durable discontinuation of systemic therapy for chronic graft-versus-host disease: myth or reality?

S. Pavletic, K. Schultz, 2022, Haematologica.

Improved survival after acute graft-versus-host disease diagnosis in the modern era

Alan M. Miller, R. Vij, W. Wood, 2017, Haematologica.

Nelarabine in Combination with Etoposide and Cyclophosphamide Is Active in First Relapse of Childhood T-Acute Lymphocytic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LL)

L. Silverman, B. Wood, C. Zwaan, 2014 .

W. Woods, J. Perentesis, S. Davies, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial

J. Wagner, J. Kurtzberg, D. Wall, 2012 .

STAT3 mutations and persistence of autoimmunity.

K. Schultz, 2013, Blood.

Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations

C. Zwaan, A. Kiani, B. De Moerloose, 2023, Leukemia.

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.

J. Kanda, R. Gale, J. Pidala, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study

S. Mostafavi, G. Reid, A. Kariminia, 2019, Pediatric hematology and oncology.

Generic formulations of imatinib for treatment of Philadelphia chromosome–positive leukemia in pediatric patients

A. Baruchel, M. Schrappe, H. Shimada, 2018, Pediatric blood & cancer.

Relationship between cyclosporine area-under-the curve and acute graft versus host disease in pediatric patients undergoing hematopoietic stem cell transplant: A prospective, multicenter study

K. Schultz, L. Sung, T. Schechter, 2018, Pediatric hematology and oncology.

Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study

M. Aljurf, J. Szer, R. Gale, 2020 .

Haploidentical transplantation in children.

K. Schultz, 2010, Blood.

Efficacy of SCRI-CAR19x22 T cell product in B-ALL and persistence of anti-CD22 activity.

Amanda M Li, V. Wu, M. Jensen, 2020 .

Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS gene

L. Notarangelo, T. Morio, H. Ochs, 2014, Journal of Clinical Immunology.

Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre‐transplant minimal residual disease reduction

L. Silverman, B. Wood, J. Whitlock, 2020, Pediatric blood & cancer.

Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.

Ming-Yu Liu, Fei Li, D. Blaise, 2023, Heliyon.

Circulating Cell Free Mitochondrial DNA As a Diagnostic and Prognostic Biomarker in Chronic and Late Acute Graft-versus-Host Disease in Children.

G. Cuvelier, K. Schultz, S. Abroun, 2022, Experimental hematology.

Bone pain caused by isolated paraspinal extramedullary relapse of childhood acute lymphoblastic leukemia

K. Schultz, S. Pritchard, A. Alessandri, 1999 .

A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.

J. Chewning, M. Verneris, M. Qayed, 2020, Blood.

Maintenance tyrosine kinase inhibitors following allo-HCT for chronic myeloid leukemia: A CIBMTR Study.

M. Aljurf, J. Szer, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

M. Loh, N. Heerema, L. Silverman, 2017 .

59: TNF-α and TNF Receptor Superfamily Member 1B Polymorphisms Predict Risk of Acute GVHD Following Matched Unrelated Donor BMT in Children

R. Ferrell, G. Yanik, E. Livote, 2008 .

Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.

R. Ferrell, G. Yanik, Yan Lin, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Expression of the adaptor protein BLNK/SLP-65 in childhood acute lymphoblastic leukemia

J. Downing, M. Ross, D. Campana, 2004, Leukemia.

Children ' s Cancer Group lymphoblastic leukemia : a combined analysis of prognostic markers Risk-and response-based classification of childhood B-precursor acute

Stephen P. Hunger, Jeffrey E. Rubnitz, Jonathan J. Shuster, 2007 .

The Relationship of Acute Gvhd and Pre- and Post-Transplant Flow-MRD to the Incidence and Timing of Relapse in Children Undergoing Allogeneic Transplantation for High Risk ALL: Defining a Target Population and Window for Immunological Intervention to Prevent Relapse

J. Gastier-Foster, S. Grupp, B. Langholz, 2012 .

Urinary TIMP-2*IGFBP-7 to diagnose acute kidney injury in children receiving cisplatin.

G. Cuvelier, R. Tsuyuki, M. Pinsk, 2023, Pediatric nephrology.

Access to Hematopoietic Stem Cell Transplantation among Pediatric Patients with Acute Lymphoblastic Leukemia: A Population-Based Analysis.

G. Cuvelier, H. Bittencourt, J. Pole, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors.

K. Myers, M. Qayed, G. Yanik, 2022, Transplantation and cellular therapy.

Impact of CD34+ Cell Dose on Outcome Among Children Undergoing Autologous Hematopoietic Stem Cell Transplant for High-Risk Neuroblastomas

M. Qayed, G. Yanik, Tristan E. Knight, 2022, Transplantation and Cellular Therapy.

Misleading leads: Bone pain caused by isolated paraspinal extramedullary relapse of childhood acute lymphoblastic leukemia.

K. Schultz, S. Pritchard, A. Alessandri, 1999, Medical and pediatric oncology.

Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC).

M. Dan, L. Lum, K. Schultz, 1992, Bone marrow transplantation.

T Cell Costimulation Blockade with CTLA4-Ig (Abatacept) for Acute Gvhd Prevention in HLA Matched and Mismatched Unrelated Donor Transplantation: Results of the First Phase 2 Trial

M. Norkin, M. Pasquini, M. Tighiouart, 2019, Biology of Blood and Marrow Transplantation.

Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial.

M. Loh, J. Gastier-Foster, N. Heerema, 2023, The Lancet. Haematology.

HLA-DM expression is elevated in ETV6-AML1 translocation-positive pediatric acute lymphoblastic leukemia.

G. Reid, W. Jastaniah, K. Schultz, 2006, Leukemia research.

Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031

N. Heerema, S. Hunger, M. Borowitz, 2014, Leukemia.

Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD

J. Ritz, Stephanie J. Lee, S. Paczesny, 2022, Blood advances.

Striking Predictive Power For Relapse and Decreased Survival Associated With Detectable Minimal Residual Disease by IGH VDJ Deep Sequencing Of Bone Marrow Pre- and Post-Allogeneic Transplant In Children With B-Lineage ALL: A Subanalysis Of The COG ASCT0431/PBMTC ONC051 Study

C. Carlson, S. Grupp, M. Kalos, 2013 .

Minimal Toxicity of Imatinib Mesylate in Combination with Intensive Chemotherapy for Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) in Children: A Report of the Children’s Oncology Group (COG) AALL0031 Protocol for Very High Risk ALL.

J. Gastier-Foster, N. Heerema, H. Sather, 2006 .

Treatment of familial erythrophagocytic lymphohistiocytosis with cyclosporine A.

Y. Ravindranath, E. Abella, K. Schultz, 1997, The Journal of pediatrics.

Continuous Dose Dasatinib Is Safe and Feasible in Combination with Intensive Chemotherapy in Pediatric Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Children's Oncology Group (COG) Trial AALL0622

M. Loh, T. Merchant, J. Gastier-Foster, 2012 .

Higher Abatacept Exposure Decreases Acute GVHD Risk Without Increasing Adverse Events.

D. Neuberg, S. Choi, B. Blazar, 2023, Blood.

Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.

N. Heerema, H. Sather, S. Hunger, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.

W. Wood, A. Gratwohl, M. Aljurf, 2014, Blood.

Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.

J. Pidala, M. Flowers, S. Pavletic, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

P. Lachenbruch, B. Reeve, S. Hirschfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study.

S. Grupp, B. Langholz, Zhengjia Chen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials.

Stephanie J. Lee, S. Pavletic, K. Schultz, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.

B. Sandmaier, M. Aljurf, R. Gale, 2019, Blood advances.

Chronic Graft versus Host Disease: Interdisciplinary Management: Pathophysiology of Chronic Graft versus Host Disease

K. Schultz, 2009 .

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow allografts have improved Long-term Overall and Graft-versus-Host Disease, Relapse-Free Survival Biol Blood Marrow Transplant.

J. Kanda, J. Pidala, M. Boyiadzis, 2019 .

B. Sandmaier, M. Aljurf, M. Grunwald, 2019, Haematologica.

TRANSPLANTATION Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality

J. Pidala, S. Santarone, M. Maiers, 2013 .

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

M. Norkin, R. Vij, W. Wood, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length

Amanda M Li, R. Schreiber, S. Stockler-Ipsiroglu, 2018, Pediatric hematology and oncology.